One-year outcome of a combination of weight loss therapies for subjects with type 2 diabetes: a randomized trial
- PMID: 12941710
- DOI: 10.2337/diacare.26.9.2505
One-year outcome of a combination of weight loss therapies for subjects with type 2 diabetes: a randomized trial
Abstract
Objective: The purpose of this study was to evaluate the effects of a combination weight loss program using intermittent low-calorie diets, energy-controlled meal replacement products, and sibutramine on weight loss, diabetes control, and cardiovascular risk factors in overweight or obese subjects with type 2 diabetes.
Research design and methods: Overweight or obese individuals with type 2 diabetes treated with diet or oral medication were randomly assigned to either a standard therapy or combination therapy group. Both groups received a standardized program to facilitate weight loss. The combination therapy group also received 10-15 mg sibutramine daily, low-calorie diets using meal replacement products for 1 week every 2 months, and between low-calorie diet weeks, once daily use of meal replacement product and snack bars to replace one usual meal and snack. Primary outcome measures were changes in body weight, glycemic control, plasma lipids, blood pressure, pulse, and body composition at 1 year.
Results: At 1 year, combination therapy, compared with standard therapy, resulted in significantly more weight loss (-7.3 +/- 1.3 kg vs. -0.8 +/- 0.9 kg, P < 0.001) and reduction in HbA(1c) (-0.6 +/- 0.3 vs. 0.0 +/- 0.2%, P = 0.05). Combination therapy resulted in reduced requirement for diabetes medications and decreased fat mass and lean body mass. A 5-kg decrease in weight at 1 year was associated with a decrease of 0.4% in HbA(1c) (P = 0.006). Changes in fasting glucose, lipids, pulse, and blood pressure did not differ between groups.
Conclusions: This combination weight loss program resulted in greater weight loss and improved diabetes control compared with a standard weight loss program in overweight or obese subjects with type 2 diabetes.
Similar articles
-
Two-year outcome of a combination of weight loss therapies for type 2 diabetes.Diabetes Care. 2005 Jun;28(6):1311-5. doi: 10.2337/diacare.28.6.1311. Diabetes Care. 2005. PMID: 15920044 Clinical Trial.
-
[Pharmacological therapy of obesity].G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):83S-93S. G Ital Cardiol (Rome). 2008. PMID: 18773755 Italian.
-
A randomized trial of sibutramine in the management of obese type 2 diabetic patients treated with metformin.Diabetes Care. 2003 Jan;26(1):125-31. doi: 10.2337/diacare.26.1.125. Diabetes Care. 2003. PMID: 12502668 Clinical Trial.
-
Dietary treatment and long-term weight loss and maintenance in type 2 diabetes.Obes Res. 2001 Nov;9 Suppl 4:348S-353S. doi: 10.1038/oby.2001.141. Obes Res. 2001. PMID: 11707564 Review.
-
Do meal replacement drinks have a role in diabetes management?Nestle Nutr Workshop Ser Clin Perform Programme. 2006;11:171-181. doi: 10.1159/000094450. Nestle Nutr Workshop Ser Clin Perform Programme. 2006. PMID: 16820739 Review.
Cited by
-
Do Incretins play a role in the remission of type 2 diabetes after gastric bypass surgery: What are the evidence?Obes Surg. 2009 Feb;19(2):217-229. doi: 10.1007/s11695-008-9696-3. Epub 2008 Sep 27. Obes Surg. 2009. PMID: 18820978 Free PMC article. Review.
-
Transcultural Lifestyle Medicine in Type 2 Diabetes Care: Narrative Review of the Literature.Am J Lifestyle Med. 2022 Jun 1;17(4):518-559. doi: 10.1177/15598276221095048. eCollection 2023 Jul-Aug. Am J Lifestyle Med. 2022. PMID: 37426734 Free PMC article. Review.
-
Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus.Cochrane Database Syst Rev. 2005 Jan 25;2005(1):CD004096. doi: 10.1002/14651858.CD004096.pub2. Cochrane Database Syst Rev. 2005. PMID: 15674929 Free PMC article.
-
The effects of different intermittent fasting regimens in people with type 2 diabetes: a network meta-analysis.Front Nutr. 2024 Jan 25;11:1325894. doi: 10.3389/fnut.2024.1325894. eCollection 2024. Front Nutr. 2024. PMID: 38332802 Free PMC article.
-
Long-term pharmacotherapy for obesity and overweight.Cochrane Database Syst Rev. 2004;2003(3):CD004094. doi: 10.1002/14651858.CD004094.pub2. Cochrane Database Syst Rev. 2004. PMID: 15266516 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous